On 28 April 2020, the European Commission published further Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) Pandemic (the “Guidance”), supported by the European Medicines Agency (EMA) and the national Heads of Medicines Agency (HMA). The Guidance is an update to the previous version published in late March (see InsideEULifeSciences blog post
Latest Post
More Posts
Effective date of EU Medical Device Regulation now officially delayed by 1 year
European Commission publishes proposal to postpone the application date of the Medical Device Regulations in response to COVID-19
European Commission plans to postpone the application date of the Medical Device Regulations in response to COVID-19
MHRA announces a risk-based prioritisation of on-site Good Practice inspections during COVID-19
TechForce19: UK Government promises up to £25,000 for innovator companies that develop digital support solutions for COVID-19
MHRA issues specification for a “Rapidly Manufactured Ventilator System” for use in hospitals during the COVID-19 outbreak
EDPB releases information note in the event of a “No-deal Brexit”
Subscribe: Subscribe via RSS
Firm/Org